Survival rates and safety associated with chemoradiotherapy followed by surgery and chemoradiotherapy alone for patients with T4 esophageal cancer: a systematic review and meta-analysis

医学 放化疗 食管癌 子群分析 放射治疗 外科 养生 存活率 内科学 癌症 肿瘤科 置信区间
作者
Chia Ching Lee,Yu Yang Soon,Balamurugan Vellayappan,Francis Ho,Jeremy Tey
出处
期刊:Acta Oncologica [Taylor & Francis]
卷期号:61 (6): 738-748 被引量:4
标识
DOI:10.1080/0284186x.2022.2062680
摘要

Background The optimal treatment approach for T4 esophageal cancer is not well established. We aimed to perform a systematic review and meta-analysis to determine the survival rates and safety of chemoradiotherapy followed by surgery (CRT-S) and chemoradiotherapy alone (CRT) in patients with T4 Nany M0 esophageal cancer.Materials and Methods We searched databases for eligible prospective or retrospective studies. The outcomes of interest were overall survival (OS) at 1, 3 and 5 years, treatment-related fistula formation and mortality rates. Meta-analyses were performed using the random effects models separately for studies evaluating CRT-S and CRT. Subgroup analyses were performed based on histology, radiation dose, chemotherapy regimen and duration of the interval between CRT and surgery.Results We identified 23 studies including 1,119 patients with predominantly squamous cell carcinoma (93%) and adenocarcinoma (3%) histology. The OS rates of patients receiving CRT-S were 65%, 36% and 20% at 1, 3 and 5 years, respectively. The OS rates of patients receiving CRT were 30%, 11% and 10% at 1, 3 and 5 years, respectively. Treatment-related fistula formation rates were 4% for CRT-S and 9% for CRT. Treatment-related mortality rates were 3% for both groups. Subgroup analyses showed that the interval of >2 months between CRT and surgery was associated with significantly improved OS rates at 1, 3 and 5 years.Conclusion Chemoradiotherapy is an efficacious treatment approach for T4 esophageal cancer, with clinically acceptable rates of treatment-related fistula formation and mortality. Tri-modality approach with surgery can be considered in carefully selected patients. Our study findings should be interpreted with caution due to the lack of high-quality evidence. Randomized controlled trials are warranted to confirm these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Neo完成签到,获得积分10
刚刚
keyaner完成签到,获得积分10
2秒前
童林艳完成签到,获得积分10
2秒前
ECHO完成签到,获得积分10
4秒前
Lucas应助Fang Xianxin采纳,获得10
5秒前
xiaoyao完成签到,获得积分10
6秒前
asss完成签到,获得积分10
6秒前
Y123发布了新的文献求助30
7秒前
LOVER完成签到 ,获得积分10
8秒前
松松完成签到 ,获得积分10
8秒前
10秒前
nater4ver完成签到,获得积分10
11秒前
UU发布了新的文献求助10
13秒前
超帅鸭子完成签到,获得积分10
13秒前
LXZ完成签到,获得积分10
13秒前
依惜完成签到,获得积分10
13秒前
zhaokunfeng关注了科研通微信公众号
13秒前
赫青亦完成签到 ,获得积分10
13秒前
exy完成签到,获得积分10
14秒前
zhaohu47完成签到,获得积分10
15秒前
超帅鸭子发布了新的文献求助10
15秒前
每每反完成签到,获得积分10
17秒前
凡凡完成签到 ,获得积分10
18秒前
19秒前
呆鹅喵喵完成签到,获得积分10
19秒前
忧心的洙完成签到,获得积分10
20秒前
123完成签到,获得积分10
20秒前
青青草完成签到,获得积分10
22秒前
Fang Xianxin完成签到,获得积分20
22秒前
yue发布了新的文献求助10
22秒前
小甘看世界完成签到,获得积分0
24秒前
量子星尘发布了新的文献求助10
24秒前
张今天也要做科研呀完成签到,获得积分10
25秒前
nater3ver完成签到,获得积分10
26秒前
26秒前
自然怀梦完成签到,获得积分10
26秒前
轻歌水越完成签到 ,获得积分10
26秒前
执意完成签到 ,获得积分10
27秒前
大模型应助Coral采纳,获得10
27秒前
songyl完成签到,获得积分10
28秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038303
求助须知:如何正确求助?哪些是违规求助? 3576013
关于积分的说明 11374210
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029